Lack of comparability of immunoassays for rheumatoid factor isotypes
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF...
Saved in:
Published in | Clinical chemistry and laboratory medicine Vol. 61; no. 9; pp. 1619 - 1622 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
De Gruyter
28.08.2023
Walter De Gruyter & Company |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.
We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.
Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).
The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice. |
---|---|
AbstractList | Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen’s kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice. Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.OBJECTIVESRheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.METHODSWe tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).RESULTSDiagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.CONCLUSIONSThe poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice. Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes. We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays. Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen's kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA). The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice. |
Author | Benucci, Maurizio Grossi, Valentina Bizzaro, Nicola Palterer, Boaz Infantino, Maria Pancani, Silvia Manfredi, Mariangela |
Author_xml | – sequence: 1 givenname: Maria orcidid: 0000-0002-6200-4467 surname: Infantino fullname: Infantino, Maria email: maria2.infantino@uslcentro.toscana.it organization: Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy – sequence: 2 givenname: Boaz surname: Palterer fullname: Palterer, Boaz organization: Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy – sequence: 3 givenname: Silvia surname: Pancani fullname: Pancani, Silvia organization: IRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy – sequence: 4 givenname: Maurizio surname: Benucci fullname: Benucci, Maurizio organization: Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy – sequence: 5 givenname: Valentina surname: Grossi fullname: Grossi, Valentina organization: Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy – sequence: 6 givenname: Mariangela surname: Manfredi fullname: Manfredi, Mariangela organization: Laboratory of Immunology and Allergology, S. Giovanni di Dio Hospital, Florence, Italy – sequence: 7 givenname: Nicola orcidid: 0000-0002-4227-6983 surname: Bizzaro fullname: Bizzaro, Nicola organization: Laboratory of Clinical Pathology, San Antonio Hospital, Azienda Sanitaria Universitaria Integrata, Udine, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37027892$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1L5TAUhoMofm9dSmE2bqo5SZq2i1kMOjrCBTe6Dmk-nGjbXJMU6b83naszIOMi5HB4nvCS9wBtj340CJ0APocKqgul-qEkmNASA2630D4wWpeMUtj-M7OScwJ76CDGJ4yhqli9i_ZojUndtGQfXa2kei68LZQf1jLIzvUuzcvCDcM0ehmjnGNhfSjCbzMNMnmnCytVyhsXfZrXJh6hHSv7aI7f70P0cP3z_vJXubq7ub38sSoVretUAumoxACEMKs5t0prbCrNsSZGG6wNI00HDDrWKis7ijvA0ipFM2Yo7eghOtu8uw7-ZTIxicFFZfpejsZPUZC6bWrAnLGMfvuEPvkpjDmdIA3lDc8xIFOn79TUDUaLdXCDDLP4-J8MnG8AFXyMwdi_CGCxFCCWAsRSgFgKyAL7JCiXZHJ-TEG6_mvt-0Z7lX0yQZvHMM15-Jf6_yKHFvKhb_NRnhQ |
CitedBy_id | crossref_primary_10_1002_admt_202301245 |
Cites_doi | 10.1002/art.11223 10.1002/art.30200 10.1007/s002960050069 10.1136/ard.2008.105759 10.1159/000066861 10.1136/ard.2003.019877 10.1016/j.autrev.2009.11.017 10.1136/rmdopen-2022-002817 10.1136/ard.2010.138461 10.1136/ard.61.6.505 10.1136/ard.52.2.161 10.1016/j.jtauto.2022.100142 10.3389/fimmu.2018.01113 10.3389/fimmu.2018.00876 10.1136/ard.59.2.149 10.1136/ard.2005.041376 10.1136/ard.2008.100677 10.1136/rmdopen-2021-002099 10.1136/annrheumdis-2017-212365 10.1186/s13075-016-0940-2 10.3389/fimmu.2021.685312 10.1515/cclm-2017-0988 10.1136/ard.44.1.13 |
ContentType | Journal Article |
Copyright | 2023 Walter de Gruyter GmbH, Berlin/Boston. 2023 Walter de Gruyter GmbH, Berlin/Boston |
Copyright_xml | – notice: 2023 Walter de Gruyter GmbH, Berlin/Boston. – notice: 2023 Walter de Gruyter GmbH, Berlin/Boston |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QO 7T7 7TK 7U7 8FD C1K FR3 P64 7X8 |
DOI | 10.1515/cclm-2023-0109 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Biotechnology Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1437-4331 |
EndPage | 1622 |
ExternalDocumentID | 37027892 10_1515_cclm_2023_0109 10_1515_cclm_2023_01096191619 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0~D 29B 354 36B 4.4 53G 5GY 5RE AAAEU AABBZ AAFPC AAGVJ AAILP AALGR AAOQK AAOWA AAPJK AAQCX AARRE AASQH AAXCG ABAOT ABAQN ABDRH ABFKT ABFQV ABIQR ABJNI ABLJU ABMIY ABPLS ABRDF ABUVI ABWLS ABXMZ ABYBW ACDEB ACEFL ACGFS ACIWK ACPMA ACPRK ACUND ACYCL ACZBO ADDWE ADEQT ADGQD ADGYE ADOZN AECWL AEDGQ AEGVQ AEICA AEJTT AENEX AEQDQ AERZL AEXIE AFBAA AFBDD AFBQV AFCXV AFGDO AFQUK AFRAH AFYRI AGBEV AHOVO AHVWV AHXUK AIERV AIWOI AJATJ AJHHK AKXKS ALMA_UNASSIGNED_HOLDINGS ALUKF ALYBR ASYPN BAKPI BBCWN BCIFA CGQUA CS3 DU5 EBS EMOBN F5P HZ~ IY9 KDIRW N9A O9- OBC OBS OEB OES OHH P2P PQQKQ QD8 RDG SA. SLJYH TEORI UK5 WTRAM AAYXX CITATION ABVMU CGR CUY CVF DBYYV ECM EIF NPM 7QO 7T7 7TK 7U7 8FD AAWFC C1K FR3 P64 7X8 ADNPR |
ID | FETCH-LOGICAL-c377t-12b3a011224fd66fcdd0e5d60d2ede0de428b141b49cfab30b10afcc3d0ee33b3 |
ISSN | 1434-6621 1437-4331 |
IngestDate | Thu Aug 07 15:17:40 EDT 2025 Mon Jun 30 04:31:20 EDT 2025 Wed Feb 19 02:06:48 EST 2025 Thu Apr 24 23:09:05 EDT 2025 Tue Jul 01 02:49:41 EDT 2025 Thu Jul 10 10:28:35 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | isotypes agreement nephelometry rheumatoid arthritis rheumatoid factor |
Language | English |
License | 2023 Walter de Gruyter GmbH, Berlin/Boston. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c377t-12b3a011224fd66fcdd0e5d60d2ede0de428b141b49cfab30b10afcc3d0ee33b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4227-6983 0000-0002-6200-4467 |
PMID | 37027892 |
PQID | 2836861121 |
PQPubID | 105421 |
PageCount | 04 |
ParticipantIDs | proquest_miscellaneous_2798710644 proquest_journals_2836861121 pubmed_primary_37027892 crossref_primary_10_1515_cclm_2023_0109 crossref_citationtrail_10_1515_cclm_2023_0109 walterdegruyter_journals_10_1515_cclm_2023_01096191619 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-08-28 |
PublicationDateYYYYMMDD | 2023-08-28 |
PublicationDate_xml | – month: 08 year: 2023 text: 2023-08-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Berlin |
PublicationTitle | Clinical chemistry and laboratory medicine |
PublicationTitleAlternate | Clin Chem Lab Med |
PublicationYear | 2023 |
Publisher | De Gruyter Walter De Gruyter & Company |
Publisher_xml | – name: De Gruyter – name: Walter De Gruyter & Company |
References | 2024030716131124245_j_cclm-2023-0109_ref_003 2024030716131124245_j_cclm-2023-0109_ref_025 2024030716131124245_j_cclm-2023-0109_ref_004 2024030716131124245_j_cclm-2023-0109_ref_005 2024030716131124245_j_cclm-2023-0109_ref_006 2024030716131124245_j_cclm-2023-0109_ref_007 2024030716131124245_j_cclm-2023-0109_ref_008 2024030716131124245_j_cclm-2023-0109_ref_009 2024030716131124245_j_cclm-2023-0109_ref_020 2024030716131124245_j_cclm-2023-0109_ref_021 2024030716131124245_j_cclm-2023-0109_ref_022 2024030716131124245_j_cclm-2023-0109_ref_001 2024030716131124245_j_cclm-2023-0109_ref_023 2024030716131124245_j_cclm-2023-0109_ref_002 2024030716131124245_j_cclm-2023-0109_ref_024 2024030716131124245_j_cclm-2023-0109_ref_014 2024030716131124245_j_cclm-2023-0109_ref_015 2024030716131124245_j_cclm-2023-0109_ref_016 2024030716131124245_j_cclm-2023-0109_ref_017 2024030716131124245_j_cclm-2023-0109_ref_018 2024030716131124245_j_cclm-2023-0109_ref_019 2024030716131124245_j_cclm-2023-0109_ref_010 2024030716131124245_j_cclm-2023-0109_ref_011 2024030716131124245_j_cclm-2023-0109_ref_012 2024030716131124245_j_cclm-2023-0109_ref_013 |
References_xml | – ident: 2024030716131124245_j_cclm-2023-0109_ref_002 doi: 10.1002/art.11223 – ident: 2024030716131124245_j_cclm-2023-0109_ref_019 – ident: 2024030716131124245_j_cclm-2023-0109_ref_022 doi: 10.1002/art.30200 – ident: 2024030716131124245_j_cclm-2023-0109_ref_020 doi: 10.1007/s002960050069 – ident: 2024030716131124245_j_cclm-2023-0109_ref_006 doi: 10.1136/ard.2008.105759 – ident: 2024030716131124245_j_cclm-2023-0109_ref_001 doi: 10.1159/000066861 – ident: 2024030716131124245_j_cclm-2023-0109_ref_013 doi: 10.1136/ard.2003.019877 – ident: 2024030716131124245_j_cclm-2023-0109_ref_004 doi: 10.1016/j.autrev.2009.11.017 – ident: 2024030716131124245_j_cclm-2023-0109_ref_017 doi: 10.1136/rmdopen-2022-002817 – ident: 2024030716131124245_j_cclm-2023-0109_ref_007 doi: 10.1136/ard.2010.138461 – ident: 2024030716131124245_j_cclm-2023-0109_ref_023 doi: 10.1136/ard.61.6.505 – ident: 2024030716131124245_j_cclm-2023-0109_ref_014 doi: 10.1136/ard.52.2.161 – ident: 2024030716131124245_j_cclm-2023-0109_ref_012 doi: 10.1016/j.jtauto.2022.100142 – ident: 2024030716131124245_j_cclm-2023-0109_ref_016 doi: 10.3389/fimmu.2018.01113 – ident: 2024030716131124245_j_cclm-2023-0109_ref_015 doi: 10.3389/fimmu.2018.00876 – ident: 2024030716131124245_j_cclm-2023-0109_ref_021 doi: 10.1136/ard.59.2.149 – ident: 2024030716131124245_j_cclm-2023-0109_ref_024 – ident: 2024030716131124245_j_cclm-2023-0109_ref_003 doi: 10.1136/ard.2005.041376 – ident: 2024030716131124245_j_cclm-2023-0109_ref_005 doi: 10.1136/ard.2008.100677 – ident: 2024030716131124245_j_cclm-2023-0109_ref_025 doi: 10.1136/rmdopen-2021-002099 – ident: 2024030716131124245_j_cclm-2023-0109_ref_010 doi: 10.1136/annrheumdis-2017-212365 – ident: 2024030716131124245_j_cclm-2023-0109_ref_009 doi: 10.1186/s13075-016-0940-2 – ident: 2024030716131124245_j_cclm-2023-0109_ref_011 doi: 10.3389/fimmu.2021.685312 – ident: 2024030716131124245_j_cclm-2023-0109_ref_008 doi: 10.1515/cclm-2017-0988 – ident: 2024030716131124245_j_cclm-2023-0109_ref_018 doi: 10.1136/ard.44.1.13 |
SSID | ssj0015547 |
Score | 2.3860104 |
Snippet | Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease.... |
SourceID | proquest pubmed crossref walterdegruyter |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1619 |
SubjectTerms | Agglutination agreement Antibodies Arthritis, Rheumatoid - diagnosis Assaying Autoantibodies Autoimmune diseases Chemiluminescence Citrulline Enzyme-Linked Immunosorbent Assay Humans Immunoassay Immunoassays Immunoglobulin A Immunoglobulin G Immunoglobulin Isotypes Immunoglobulin M Isotypes Nephelometry Rheumatoid arthritis Rheumatoid Factor Turbidimetry |
Title | Lack of comparability of immunoassays for rheumatoid factor isotypes |
URI | https://www.degruyter.com/doi/10.1515/cclm-2023-0109 https://www.ncbi.nlm.nih.gov/pubmed/37027892 https://www.proquest.com/docview/2836861121 https://www.proquest.com/docview/2798710644 |
Volume | 61 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF6FVuJ4qKBcgYKMhMRD5GJ7fT42IW1BaUEiQX2z9gRLwUZJDGr-BH-ZWe_6SFMQ8BJZm413M_N595sdzwxCL4XAMeOC2AH2I9t3pWcnPIhtIgNGgcxRLtU55Nl5eDrz310EF73ez85bS-WKHrL1tXEl_6NVaAO9qijZf9Bsc1NogGvQL3yChuHzr3Q8Iax5L5wsdMbtymOeqaiPAngxuazyLQwWX0QJ3LTIuKmwM8iWhTp-XXbZ6agOk2R1GbjKt2CAorzxV13xb3NJVK2JwsT9ZM0q_6Hyw2tADAuybttzputIDT5m8-_tD4YiLxnL9I3KRbbWb4jVRxIeVmesJsS7WviqAWDBHJwsykt1qVC8tb4BU_PtMNQB0oeibovaIC6zQOts7QaISWe1BbaadHZuN9Qhzlu7QlAl0GBs_tXW03WdpN3_ap__-fv0eDaZpNPxxfQG2vXA7oCFc_foZDj-1DimgH1V9XrquZs8oDDC6837b_KcLePlDtr7UYmJi89aSB1aM72L9ow9Yh1pcN1DPZHvo1ujWv_76OaZUfl99EbhzSqktYE31dDFmwV4s1q8WRpvVo23B2h2PJ6OTm1ThcNmOIpWtutRTGAXAK4neRhKxrkjAh463BNcOFyAAUtd36V-wiSh2KGuQyRjGLoJjCl-iHbyIhePkQVciPs8ApNcSl9ENCaxI0gIemNe4EW0j-xaZikzKepVpZR5qkxVkHGqZJwqGadKxn30qun_TSdn-W3Pg1oFqXmAlykw6zAO4Z-5ffSi-RrEq3xmJBdFCX2iJAYSDlZDHz3SqmuGwpFy2ydeH4VXdNmOcf10ALcKu0_-PKun6Hb7dB2gndWiFM-AAq_ocwPLX8q2tfQ |
linkProvider | Walter de Gruyter |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fU9QwEN7RY0b0ARVRKqh1xhmfwrVNmraPiOCpdzyBw1snP-WG48rcteMcfz0b0isI-qKvbdokm03222zyLcAHY2iutBEkpSwjLLYJKXSaE2FTJRHMSW3dPuTokA-O2beT9OTWXRh3rFKbn7NmUXuG1L6uVOM2yjquAbTAfaUm58Rl_iYutNM_rc8nD2Eld0wsPVjZ_fJp_0cXS0CDeZ1ihVFGOE_ilrrx_m9-N0338OYTWPt1HcLu2nfLEh08BbXsgz-AcrbT1HJHXd6hd_y_Tj6DtRaohrtes57DAzNdh9W9ZX64dXg0asPyL-DzUKizsLKhP9Huqb8X7sHYXT-pEKCLxTxEfBzOTk2DILka69Cn-gnH88rtA8834Phg_2hvQNr0DETRLKtJnEgqcHlAEGA151ZpHZlU80gnRptIG_RsZMxiyQplhaSRjCNhlaJYzFAq6UvoTaup2YQQjaRmOkNfzVpmMpmLPDKCxzxRSZpkMgCyHJlStdzlLoXGpHQ-DMqqdLIqnaxKJ6sAPnblLzxrx19Lbi8Humxn77xEyMVzjj2LA3jfvUbxumCKmJqqwTJZgb4mAjoWwCuvIF1VNHPx3CIJgN_RmJs6_twcdGcRghev__XDd7A6OBoNy-HXw-9b8NgrDy6F-Tb06llj3iCCquXbdopcAZX1F7A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BVirlUKC0EFogSEic3I1jx0mOfS0F2ooDRdwiP2HVsqk2iartr2fcPIAWLnBNxrE9Hnu-8UxmAF5byzJtrCQJ4ynh1MUkN0lGpEu0QjCnjPP3kMcn4vCUv_-S9NGEVRdWaezXebOo2wypY1Pqxl-UDbkGUAOPtT7_Tnzlb-JdO-ML4-7CUsZplI1gaeft7sHnwZWA-vK6wgpnnAgR0y5z4-2v_K6ZbsHN-7B6ee3BHob3iyKaPADVT6GNPznbbmq1ra9uZHf8rzk-hNUOpoY7rVw9gjt2tgb39vrqcGuwfNw55R_D_pHUZ2HpwjaevU38vfAPpv7nkxLhuVxUIaLjcP7NNgiRy6kJ20I_4bQq_S1wtQ6nk4NPe4ekK85ANEvTmtBYMYmHA0IAZ4Rw2pjIJkZEJrbGRsaiXaMop4rn2knFIkUj6bRmSGYZU2wDRrNyZp9CiCrScJOipeYct6nKZBZZKaiIdZzEqQqA9AtT6C5zuS-gcV54CwZZVXhWFZ5VhWdVAG8G-os2Z8dfKbf6dS66vVsVCLhEJnBmNIBXw2tkr3elyJktG6RJc7Q0Ec7xAJ608jF0xVLvzc3jAMQNgfnZx5-Hg8YsAvD82b82fAnLH_cnxdG7kw-bsNKKDp6D2RaM6nljnyN8qtWLboP8ADjbFlc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lack+of+comparability+of+immunoassays+for+rheumatoid+factor+isotypes&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Infantino%2C+Maria&rft.au=Palterer%2C+Boaz&rft.au=Pancani%2C+Silvia&rft.au=Benucci%2C+Maurizio&rft.date=2023-08-28&rft.pub=Walter+De+Gruyter+%26+Company&rft.issn=1434-6621&rft.eissn=1437-4331&rft.volume=61&rft.issue=9&rft.spage=1619&rft.epage=1622&rft_id=info:doi/10.1515%2Fcclm-2023-0109&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon |